Strategic · BiotechQuiver Bioscience: StrategicDevelops therapeutics for central nervous system disordersPublished Oct 4, 2026By RoundOS Funding deskFunding historyApr 13, 2026Strategic · This roundUndisclosedSourcesbusinesswire.com↗
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.UndisclosedSeed · Oct 23, 2026
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200MPrivate financing · Oct 23, 2026
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237MSeries E · Oct 23, 2026
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8BSeries C debt second close · Oct 23, 2026